Connect with us

Hi, what are you looking for?

Sunday, Nov 9, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "asthma"

Keensight Capital takes majority stake in UK breath analysis device maker

Keensight Capital takes majority stake in UK breath analysis device maker

Medical and Pharmaceutical

Keensight Capital takes majority stake in breath analysis device maker

"Quick and non-invasive breath analysis is the new blood test," says Bedfont Scientific

Rowan DunneOctober 23, 2025

Regeneron Pharmaceuticals gets access to biometric data for 15 million people

Regeneron Pharmaceuticals gets access to biometric data for 15 million people

Medical and Pharmaceutical

Regeneron Pharmaceuticals gets access to biometric data for 15 million people

When 23andMe collapsed financially, its genetic data quickly attracted attention as a lucrative asset

Joseph MortonMay 20, 2025

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

Medical and Pharmaceutical

RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement

The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world

Rowan DunneDecember 23, 2024

World Lung Day highlights need for improved lung cancer testing rates

World Lung Day highlights need for improved lung cancer testing rates

Health & Wellness

World Lung Day highlights need for improved lung cancer screening rates

Combatting air pollution and quitting smoking are also key themes

Rowan DunneSeptember 25, 2024

More Posts